Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,393 | -13,291 | -1,348 | 490,663 | 403,234 |
| Depreciation Amortization | 37,987 | 24,153 | 11,626 | 40,891 | 30,208 |
| Income taxes - deferred | -9,808 | -4,276 | -1,520 | 42,318 | 35,307 |
| Accounts receivable | 93,180 | 89,968 | 82,407 | -22,272 | 3,502 |
| Accounts payable and accrued liabilities | 3,625 | 1,639 | -235 | -1,578 | 1,890 |
| Other Working Capital | 95,465 | 86,893 | 68,341 | -45,082 | -29,321 |
| Other Operating Activity | -73,622 | -80,818 | -74,197 | 31,037 | -8,178 |
| Operating Cash Flow | $118,434 | $104,268 | $85,074 | $535,977 | $436,642 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48,754 | -32,927 | -7,868 | -17,090 | -10,876 |
| Net Acquisitions | -69,622 | -69,622 | -69,731 | -238,349 | -238,216 |
| Other Investing Activity | 8,969 | 8,662 | 7,869 | -12,173 | 0 |
| Investing Cash Flow | $-109,407 | $-93,887 | $-69,730 | $-267,612 | $-249,092 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 8,455 | 8,455 |
| Debt Repayment | -4,270 | -2,786 | -1,360 | -13,895 | -12,535 |
| Common Stock Issued | 331 | N/A | N/A | N/A | 1,993 |
| Other Financing Activity | -57,621 | -59,557 | -17,849 | -182,059 | -119,289 |
| Financing Cash Flow | $-61,560 | $-62,343 | $-19,209 | $-187,499 | $-121,376 |
| Beginning Cash Position | 632,138 | 632,138 | 632,138 | 551,272 | 551,272 |
| End Cash Position | 579,605 | 580,176 | 628,273 | 632,138 | 617,446 |
| Net Cash Flow | $-52,533 | $-51,962 | $-3,865 | $80,866 | $66,174 |
| Free Cash Flow | |||||
| Operating Cash Flow | 118,434 | 104,268 | 85,074 | 535,977 | 436,642 |
| Capital Expenditure | -48,754 | -32,927 | -7,868 | -17,090 | -10,876 |
| Free Cash Flow | 69,680 | 71,341 | 77,206 | 518,887 | 425,766 |